Evidence map›Paper›PMID 34760200›Full record

ArticleChemical science2021

Late-stage modification of peptides and proteins at cysteine with diaryliodonium salts.

Stephen A Byrne, Max J Bedding, Leo Corcilius, Daniel J Ford, Yichen Zhong, Charlotte Franck, Mark Larance, Joel P Mackay, Richard J Payne

Abstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Peptide modificationChemical science · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stephen A ByrneSchool of Chemistry, The University of Sydney Sydney NSW 2006 Australia richard.payne@sydney.edu.au.ORCID https://orcid.org/0000-0002-2098-409X
Max J BeddingSchool of Chemistry, The University of Sydney Sydney NSW 2006 Australia richard.payne@sydney.edu.au.ORCID https://orcid.org/0000-0001-6133-6681
Leo CorciliusSchool of Chemistry, The University of Sydney Sydney NSW 2006 Australia richard.payne@sydney.edu.au.
Daniel J FordSchool of Chemistry, The University of Sydney Sydney NSW 2006 Australia richard.payne@sydney.edu.au.
Yichen ZhongSchool of Life and Environmental Sciences, The University of Sydney Sydney NSW 2006 Australia.
Charlotte FranckSchool of Chemistry, The University of Sydney Sydney NSW 2006 Australia richard.payne@sydney.edu.au.
Mark LaranceSchool of Life and Environmental Sciences, The University of Sydney Sydney NSW 2006 Australia.
Joel P MackayAustralian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney Sydney NSW 2006 Australia.ORCID https://orcid.org/0000-0001-7508-8033
Richard J PayneSchool of Chemistry, The University of Sydney Sydney NSW 2006 Australia richard.payne@sydney.edu.au.ORCID https://orcid.org/0000-0002-3618-9226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The modification of peptides and proteins has emerged as a powerful means to efficiently prepare high value bioconjugates for a range of applications in chemical biology and for the development of next-generation therapeutics. Herein, we report a novel method for the chemoselective late-stage modification of peptides and proteins at cysteine in aqueous buffer with suitably functionalised diaryliodonium salts, furnishing stable thioether-linked synthetic conjugates. The power of this new platform is showcased through the late-stage modification of the affibody zEGFR and the histone protein H2A.

Identifiers

PMID34760200
PMCPMC8565360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.